CenterVue Inc. recently announced it has received 510(k) clearance for its Fixation Training for the MAIA platform — a technology that helps patients rehabilitate from vision loss using audio feedback.
The designation will reportedly allow CenterVue to initiate clinical trials of the device and continue development. According to CenterVue, the MAIA Microperimeter is used to assess a patient's visual function and fixation stability. Fixation Training can then be used if the area of fixation within a patient's retina is inadequate to provide stable vision. The Fixation Training uses a projected stimulus that is moved to different position while an auditory tone signals to the patient that stable vision has been achieved. By repeated test and response, the patient can learn to reposition their eye to achieve improved fixation stability, ultimately helping them regain the ability to read, recognize faces and achieve an overall improved quality of life.
Click here to read the full press release